Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endogenous antioxidant defense mechanisms comprise the body's primary means of protecting itself from oxidative stress via a network of enzymes (such as superoxide dismutase, catalase, and glutathione peroxidase) and non-enzymatic molecules (such as glutathione and melatonin). These systems neutralize reactive oxygen and nitrogen species, repair or mitigate oxidative damage, and maintain redox balance, serving crucial roles in preventing cardiovascular, neurodegenerative, cancerous, and other oxidative stress-related diseases. Because this refers to a biological process rather than a distinct molecule or receptor, it is not considered a canonical therapeutic target and encompasses a variety of molecular entities acting together.
Scavenging of reactive oxygen species Catalysis of redox reactions (conversion of ROS to less harmful species) Regeneration of other antioxidants (e.g., GSH regenerates oxidized vitamin C and E) Upregulation of antioxidant enzyme expression (e.g., via Nrf2 signaling)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous antioxidant defense mechanisms.